Analyst firms · Citigroup · CME

Citigroup CME price target and rating history

CME Group Inc. (CME) · Finance

Citigroup rates CME Group Inc. (CME) Buy with a $300 price target, as of its latest action on Sep 25, 2025. It has published 4 rating actions on CME since February 2022, including 1 upgrade and 1 downgrade. Across 5 firms with a CME price target in the last 12 months, the median target is $305.

Current rating

Buy

Price target

$300

Median target, all firms

$305

Actions on CME

4

Citigroup price target on CME

Every Citigroup rating on CME

• Sep 25, 2025
  UpgradeCitigroup upgrades to Buy from Neutral, price target $300
• Jan 6, 2025
  DowngradeCitigroup downgrades to Neutral from Buy, price target $255 to $250
• Oct 12, 2022
  InitiateCitigroup starts coverage at Buy, price target $220
• Feb 10, 2022
  ReiterateCitigroup raises its price target to $280 from $260, keeps Buy

How other firms rate CME

Each firm's latest rating and stated target in the last 12 months.

Questions about Citigroup and CME

What is Citigroup's price target for CME?

Citigroup's latest stated price target for CME Group Inc. (CME) is $300, from its action on Sep 25, 2025.

What is Citigroup's rating on CME?

Citigroup rates CME Buy, a bullish rating, as of Sep 25, 2025.

When did Citigroup last change its view on CME?

On Sep 25, 2025, Citigroup upgrades to Buy from Neutral, price target $300.

How does Citigroup's CME target compare with other analysts?

Across 5 firms with a CME price target in the last 12 months, the median target is $305.

More CME rating histories

• Deutsche Bank4
• Morgan Stanley5
• Raymond James5
• BofA Securities4
• Credit Suisse4
• Rosenblatt4
• Atlantic Equities4

All Citigroup ratingsCME news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.